eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Amgen Ltd
240 Cambridge Science Park, Milton Road, Cambridge, CB4 0WD
Telephone: +44 (0)1223 420 305
Fax: +44 (0)1223 426 314
Medical Information Direct Line: +44 (0)1223 436 441
Medical Information e-mail: gbinfoline@amgen.com
Customer Care direct line: +44 (0)808 0100 321
Medical Information Fax: +44 (0)1223 426 314

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 13/12/2011
PIL ARANESP PFS

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 13/12/2011 and displayed until Current
Reasons for adding or updating:
  • Correction of spelling/typing errors
  • Change to side-effects
  • Change/addition of instructions for reconstitution and/ or administration
Updated on 31/03/2011 and displayed until 13/12/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to storage instructions
  • Change to drug interactions
  • Change to information about driving or using machinery
Updated on 24/03/2011 and displayed until 31/03/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to storage instructions
  • Change to drug interactions
  • Change to information about driving or using machinery
  • PIL Submitted in error
Updated on 03/02/2011 and displayed until 24/03/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 09/09/2010 and displayed until 03/02/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 07/05/2010 and displayed until 09/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 21/12/2009 and displayed until 07/05/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to instructions about overdose
  • Change to side-effects
Updated on 15/12/2008 and displayed until 21/12/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 30/10/2008 and displayed until 15/12/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 21/04/2008 and displayed until 30/10/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 19/03/2008 and displayed until 21/04/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to how to administer the medicine
  • Improved Electronic Presentation
Updated on 06/11/2007 and displayed until 19/03/2008
Reasons for adding or updating:
  • Changes to therapeutic indications
Updated on 06/11/2007 and displayed until 06/11/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 26/07/2007 and displayed until 06/11/2007
Reasons for adding or updating:
  • Introduction of new strength
Updated on 19/01/2007 and displayed until 26/07/2007
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 17/01/2007 and displayed until 19/01/2007
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 14/06/2006 and displayed until 17/01/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
Updated on 22/03/2006 and displayed until 14/06/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to date of revision
Updated on 01/11/2005 and displayed until 22/03/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 27/07/2005 and displayed until 01/11/2005
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 10/05/2004 and displayed until 27/07/2005
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  darbepoetin alfa